• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用模拟患者方法的在线肢端肥大症咨询中,有无 Acromegaly Disease Activity Tool ACRODAT 对共同决策和共病检测的影响。

Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT using the simulated person approach.

机构信息

Department of Neurosurgery and Spine Surgery, Member of ENDO-ERN, University Hospital Essen, Essen, Germany.

Institute for Medical Education, University of Duisburg-Essen, Essen, Germany.

出版信息

Pituitary. 2024 Oct;27(5):545-554. doi: 10.1007/s11102-024-01460-6. Epub 2024 Sep 25.

DOI:10.1007/s11102-024-01460-6
PMID:39320650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11513722/
Abstract

OBJECTIVE

A patient-centered approach to the management of acromegaly includes disease activity control, shared decision-making and identification of comorbidities. The Acromegaly Disease Activity Tool (ACRODAT) is intended to assist physicians in providing such holistic management. The present study investigated this claim using the simulated person (SP) approach.

METHODS

We studied patient-doctor interaction via online video consultation in a randomized prospective study design with SPs trained to simulate a specific acromegaly profile. We analyzed the proportion of conversation time devoted to health content and the specific acromegaly and comorbidity relevant categories mentioned in the conversation. We collected physicians' feedback on the usefulness of ACRODAT, SPs subjective perception of the quality of the conversation and compared consultations with and without ACRODAT using a qualitative approach.

RESULTS

The sample (N = 30) consisted of endocrinologists treating patients with acromegaly in Germany. For SP-physician interactions (N = 60), the proportion of time spent on conversation content (e.g. IGF-I, quality of life) was distributed according to the focus of the patient profile. Comorbidities were less well identified than the need for a change in therapy. Only 18.3% of the SPs were actively asked to participate in the decision-making process. ACRODAT did not lead to any significant differences in the course of the discussion.

CONCLUSIONS

Shared decision-making was underrepresented in this SP-physician interaction in acromegaly management. Physicians adapted the content of the discussion to the SP's needs, but did not adequately address comorbidities. According to the analysis criteria used, ACRODAT did not contribute to a more holistic patient management in the present study.

摘要

目的

以患者为中心的肢端肥大症管理方法包括疾病活动控制、共同决策和共病识别。肢端肥大症疾病活动工具(ACRODAT)旨在帮助医生进行这种整体管理。本研究使用模拟人(SP)方法对此进行了研究。

方法

我们通过在线视频咨询进行了一项随机前瞻性研究设计,对接受过特定肢端肥大症模拟培训的 SP 进行了患者-医生互动研究。我们分析了用于健康内容的对话时间比例,以及对话中提到的特定肢端肥大症和共病相关类别。我们收集了医生对 ACRODAT 的有用性的反馈意见、SP 对对话质量的主观感知,并使用定性方法比较了有和没有 ACRODAT 的咨询。

结果

该样本(N=30)由德国治疗肢端肥大症患者的内分泌科医生组成。对于 SP-医生的互动(N=60),用于对话内容(例如 IGF-I、生活质量)的时间比例根据患者的病情焦点分布。与治疗方案改变相比,共病的识别较差。只有 18.3%的 SP 被积极邀请参与决策过程。ACRODAT 并未导致讨论过程中的任何显著差异。

结论

在这种肢端肥大症管理中的 SP-医生互动中,共同决策的代表性不足。医生根据 SP 的需求调整讨论内容,但没有充分解决共病问题。根据使用的分析标准,ACRODAT 在本研究中并未为更全面的患者管理做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/df3ca320a1f1/11102_2024_1460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/1e2861cc92f8/11102_2024_1460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/26284451521c/11102_2024_1460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/f6fa1f949c65/11102_2024_1460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/df3ca320a1f1/11102_2024_1460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/1e2861cc92f8/11102_2024_1460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/26284451521c/11102_2024_1460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/f6fa1f949c65/11102_2024_1460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e0/11513722/df3ca320a1f1/11102_2024_1460_Fig4_HTML.jpg

相似文献

1
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT using the simulated person approach.使用模拟患者方法的在线肢端肥大症咨询中,有无 Acromegaly Disease Activity Tool ACRODAT 对共同决策和共病检测的影响。
Pituitary. 2024 Oct;27(5):545-554. doi: 10.1007/s11102-024-01460-6. Epub 2024 Sep 25.
2
Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study.肢端肥大症疾病活动度的 ACRODAT ® 评估:西班牙的一项横断面研究:ACROVAL 研究。
Endocrine. 2022 Feb;75(2):525-536. doi: 10.1007/s12020-021-02900-0. Epub 2021 Oct 19.
3
Development of ACRODAT, a new software medical device to assess disease activity in patients with acromegaly.ACRODAT 的研发,一款新的软件医疗器械,用于评估肢端肥大症患者的疾病活动度。
Pituitary. 2017 Dec;20(6):692-701. doi: 10.1007/s11102-017-0835-5.
4
Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.问卷与工具:肢端肥大症诊断和管理中的临床有力工具。
J Endocrinol Invest. 2022 Oct;45(10):1823-1834. doi: 10.1007/s40618-022-01782-x. Epub 2022 Mar 23.
5
AcroVoice: eliciting the patients' perspective on acromegaly disease activity.AcroVoice:从患者角度了解肢端肥大症的疾病活动情况。
Pituitary. 2019 Feb;22(1):62-69. doi: 10.1007/s11102-018-00933-9.
6
The Effect of Screen-to-Screen Versus Face-to-Face Consultation on Doctor-Patient Communication: An Experimental Study with Simulated Patients.屏幕对屏幕咨询与面对面咨询对医患沟通的影响:一项针对模拟患者的实验研究
J Med Internet Res. 2017 Dec 20;19(12):e421. doi: 10.2196/jmir.8033.
7
Conversation topics in psychiatric consultations conducted with and without a shared decision-making tool: A qualitative content analysis.精神科咨询中使用和不使用共同决策工具的会话主题:定性内容分析。
Patient Educ Couns. 2024 Jan;118:108045. doi: 10.1016/j.pec.2023.108045. Epub 2023 Oct 31.
8
Prospectively investigating the impact of AI onshared decision-making in post kidney transplant care (PRIMA-AI): protocol for a longitudinal qualitative study among patients, their support persons and treating physicians at a tertiary care centre.前瞻性研究人工智能在肾移植后护理中的共享决策中的影响(PRIMA-AI):在一家三级护理中心对患者、其支持人员和治疗医生进行的纵向定性研究方案。
BMJ Open. 2024 Oct 1;14(10):e081318. doi: 10.1136/bmjopen-2023-081318.
9
Evaluation of a shared decision-making communication skills training for physicians treating patients with asthma: a mixed methods study using simulated patients.评估一种用于治疗哮喘患者的医患沟通技能培训方案对医生的效果:一项使用模拟患者的混合方法研究。
BMC Health Serv Res. 2019 Aug 30;19(1):612. doi: 10.1186/s12913-019-4445-y.
10
How does physicians' decisional conflict influence their ability to address treatment outcomes in a decision-making encounter with an advanced-stage cancer simulated patient? A descriptive study.医生的决策冲突如何影响他们在与晚期癌症模拟患者的决策中解决治疗结果的能力?一项描述性研究。
Patient Educ Couns. 2020 Sep;103(9):1752-1759. doi: 10.1016/j.pec.2020.03.008. Epub 2020 Mar 28.

引用本文的文献

1
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy.用于评估肢端肥大症疾病活动度的ACRODAT和SAGIT:意大利威尼托地区的一项多中心研究
Pituitary. 2025 Jun 22;28(4):76. doi: 10.1007/s11102-025-01543-y.

本文引用的文献

1
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders.开发并验证了一种新的治疗依从性、满意度和知识问卷(TASK-Q),用于评估成年下丘脑-垂体疾病患者。
Pituitary. 2024 Oct;27(5):673-684. doi: 10.1007/s11102-024-01425-9. Epub 2024 Jul 8.
2
The effect of coping strategies on health-related quality of life in acromegaly patients.应对策略对肢端肥大症患者健康相关生活质量的影响。
Endocrine. 2024 Jun;84(3):1108-1115. doi: 10.1007/s12020-024-03813-4. Epub 2024 Apr 13.
3
Consensus on criteria for acromegaly diagnosis and remission.
关于肢端肥大症诊断和缓解标准的共识。
Pituitary. 2024 Feb;27(1):7-22. doi: 10.1007/s11102-023-01360-1. Epub 2023 Nov 3.
4
Acromegaly: pathogenesis, diagnosis, and management.肢端肥大症:发病机制、诊断与治疗。
Lancet Diabetes Endocrinol. 2022 Nov;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3. Epub 2022 Oct 6.
5
Shared decision-making in the management of patients with inflammatory bowel disease.炎症性肠病患者管理中的共同决策。
World J Gastroenterol. 2022 Jul 14;28(26):3092-3100. doi: 10.3748/wjg.v28.i26.3092.
6
Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.问卷与工具:肢端肥大症诊断和管理中的临床有力工具。
J Endocrinol Invest. 2022 Oct;45(10):1823-1834. doi: 10.1007/s40618-022-01782-x. Epub 2022 Mar 23.
7
Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study.肢端肥大症疾病活动度的 ACRODAT ® 评估:西班牙的一项横断面研究:ACROVAL 研究。
Endocrine. 2022 Feb;75(2):525-536. doi: 10.1007/s12020-021-02900-0. Epub 2021 Oct 19.
8
Illness-related burden, personal resources and need for support in patients with acromegaly: Results of a focus group analysis.肢端肥大症患者的疾病相关负担、个人资源和支持需求:焦点小组分析的结果。
Growth Horm IGF Res. 2021 Oct-Dec;60-61:101422. doi: 10.1016/j.ghir.2021.101422. Epub 2021 Aug 5.
9
Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatologic Disease Care.了解患者偏好在风湿性疾病护理差异中的作用和挑战。
Rheum Dis Clin North Am. 2021 Feb;47(1):83-96. doi: 10.1016/j.rdc.2020.09.003. Epub 2020 Oct 29.
10
Multidisciplinary management of acromegaly: A consensus.肢端肥大症的多学科管理:共识。
Rev Endocr Metab Disord. 2020 Dec;21(4):667-678. doi: 10.1007/s11154-020-09588-z. Epub 2020 Sep 10.